Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Retia 2

K-Number: K180293 · 2018-05-30

Decision Date2018-05-30
Product CodeMYC
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

Retia 2 is the device name listed in this FDA 510(k) record. The listed applicant is Centervue S.P.A.. It received FDA 510(k) clearance on 2018-05-30 under 510(k) number K180293. The device is classified under product code MYC. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Retia 2?

Retia 2 is a medical device that received FDA 510(k) clearance on 2018-05-30. The listed applicant is Centervue S.P.A.. The 510(k) number is K180293.

When did Retia 2 receive FDA 510(k) clearance?

Retia 2 received FDA 510(k) clearance on 2018-05-30, under 510(k) number K180293.

Who is the listed applicant for Retia 2?

The FDA 510(k) record lists Centervue S.P.A. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Retia 2?

The FDA product code for Retia 2 is MYC.

Other records listing Centervue S.P.A. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 8 devices →

Related Devices (Code: MYC)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.